Literature DB >> 25384698

The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer.

Jong Hoon Lee1, Jong Hee Hyun, Dae Yong Kim, Byong Chul Yoo, Ji Won Park, Sun Young Kim, Hee Jin Chang, Byung Chang Kim, Tae Hyun Kim, Jae Hwan Oh, Dae Kyung Sohn.   

Abstract

BACKGROUND: To perform chemoradiotherapy (CRT) effectively, it is clinically beneficial to identify predictors of tumor response after CRT. This study examined the association between plasma fibrinogen level before preoperative CRT and tumor response in advanced rectal cancer.
METHODS: This was a retrospective study of 947 patients who received preoperative CRT followed by curative surgery for primary rectal cancer. We analyzed clinical factors that could be associated with pathologic tumor response in terms of downstaging (ypStage 0-I), primary tumor regression (ypT0-1), and complete response (ypT0N0).
RESULTS: Downstaging was observed in 366 patients (38.6%), primary tumor regression in 187 patients (19.7%) and complete response in 138 patients (14.6%). Multivariate analysis found that pre-CRT carcinoembryonic antigen (CEA) level, fibrinogen level, hemoglobin level, clinical T and N classification, distance from anal verge, and histologic grade were significant predictive factors for downstaging; CEA level, fibrinogen level, and N classification predicted primary tumor regression; CEA level, and fibrinogen level were predictive for complete response.
CONCLUSIONS: This study demonstrated that fibrinogen level was a significant predictor of pathologic tumor response after preoperative CRT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25384698     DOI: 10.1245/s10434-014-3962-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

Review 1.  Non-operative management of rectal cancer: understanding tumor biology.

Authors:  Iris H Wei; Julio Garcia-Aguilar
Journal:  Minerva Chir       Date:  2018-05-24       Impact factor: 1.000

Review 2.  Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review.

Authors:  Byong Chul Yoo; Seung-Gu Yeo
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

3.  A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.

Authors:  Franscois Runau; Anna Collins; Glenn Ace Fenech; Eleanor Ford; Nikoletta Dimitriou; Sanjay Chaudhri; Justin M C Yeung
Journal:  Int J Colorectal Dis       Date:  2016-11-24       Impact factor: 2.571

4.  Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer.

Authors:  Corrado Pedrazzani; Guido Mantovani; Gian Luca Salvagno; Elisabeth Baldiotti; Andrea Ruzzenente; Calogero Iacono; Giuseppe Lippi; Alfredo Guglielmi
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

5.  Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas.

Authors:  Zhen-Qiang He; Hao Duan; Chao Ke; Xiang-Heng Zhang; Cheng-Cheng Guo; Fuad Al-Nahari; Ji Zhang; Zheng-He Chen; Yin-Sheng Chen; Zhi-Gang Liu; Jian Wang; Zhong-Ping Chen; Xiao-Bing Jiang; Yong-Gao Mou
Journal:  Oncotarget       Date:  2017-07-25

6.  Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.

Authors:  Ombretta Repetto; Valli De Re; Antonino De Paoli; Claudio Belluco; Lara Alessandrini; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Oncotarget       Date:  2017-04-25

Review 7.  Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.

Authors:  Delphine Dayde; Ichidai Tanaka; Rekha Jain; Mei Chee Tai; Ayumu Taguchi
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

8.  Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer.

Authors:  Danielle S Bitterman; Lucas Resende Salgado; Harvey G Moore; Nicholas J Sanfilippo; Ping Gu; Ioannis Hatzaras; Kevin L Du
Journal:  Front Oncol       Date:  2015-12-22       Impact factor: 6.244

9.  Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.

Authors:  Chengquan Ma; Bingxin Lu; Chengwen Diao; Kun Zhao; Xinpeng Wang; Baojing Ma; Baojian Lu; Erlin Sun
Journal:  Onco Targets Ther       Date:  2016-08-08       Impact factor: 4.147

10.  Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment.

Authors:  Edyta Wolny-Rokicka; Katarzyna Brzeźniakiewicz-Janus; Jerzy Wydmański; Andrzej Tukiendorf; Agnieszka Zembroń-Łacny
Journal:  J Int Med Res       Date:  2018-03-19       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.